Owlstone Medical has secured a $5 million equity investment and initial $1.5 million grant funding, committed by the Bill and ...

At Reuters Pharma USA last month, pharmaphorum editor-in-chief Jonah Comstock caught up with Meruno Perugini, president of ...

Fast forward to 2033, and the number of patients with end stage kidney disease requiring dialysis could increase by nearly ...

The new generative AI (GenAI) develops molecules from scratch in a way that precisely matches the protein they are intended ...

The new generative AI (GenAI) develops molecules from scratch in a way that precisely matches the protein they are intended ...

While the details of the deal have remained under wraps, a report from the Wall Street Journal revealed that approximately ...

The cycle from hot to cold to hot again can take 10-15 years and a new technology may go through more than one such cycle (as ...

The San Francisco-based company has emerged from the incubators of ARCH Venture Partners and Foresite Labs with more than $1 ...

Anyone who has taken a psychiatric medication knows that the status quo in prescribing is a trial and error approach, with ...

Endeavor BioMedicines has completed a third round financing, raising an impressive $132.5 million to fund trials of its two ...

Leqembi was launched at the start of last year after an accelerated approval for patients with Alzheimer’s and confirmed ...

Back for its 9th consecutive year and gathering over 250 leaders in the space, the Microbiome Movement Drug Development ...